Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is LAVA Therapeutics NV's price target?
Analysts forecast that LAVA Therapeutics NV's price target is USD 1.50, with the highest forecast at USD 1.50 and the lowest forecast at USD 1.50.
How have LAVA Therapeutics NVLVTX's recent earnings per share performed?
The market expectation was USD -0.27, while LAVA Therapeutics NVLVTX's earnings per share (EPS) for the previous quarter was USD -0.32. EPS for the next quarter is expected at USD -0.26.